首页> 美国卫生研究院文献>Neuro-Oncology >Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database
【2h】

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

机译:胶质母细胞瘤患者同时放化疗的放疗开始时间短:来自NRG肿瘤学/放射治疗肿瘤学组数据库的次要分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundWe previously reported the unexpected finding of significantly improved survival for newly diagnosed glioblastoma in patients when radiation therapy (RT) was initiated later (>4 wk post-op) compared with earlier (≤2 wk post-op). In that analysis, data were analyzed from 2855 patients from 16 NRG Oncology/Radiotherapy Oncology Group (RTOG) trials conducted prior to the era of concurrent temozolomide (TMZ) with RT. We now report on 1395 newly diagnosed glioblastomas from 2 studies, treated with RT and concurrent TMZ followed by adjuvant TMZ. Our hypothesis was that concurrent TMZ has a synergistic/radiosensitizing mechanism, making RT timing less significant.
机译:背景我们以前曾报道过意外发现,在较晚(≤2 wk)开始放疗(术后4周)时,新诊断的胶质母细胞瘤患者的生存率显着提高。在该分析中,分析了在并发替莫唑胺(TMZ)时代之前进行的16例NRG肿瘤/放射治疗肿瘤学组(RTOG)试验中的2855名患者的数据。现在,我们从2项研究中报告了1395例新诊断的胶质母细胞瘤,这些患者接受了RT和并发TMZ治疗,随后是佐剂TMZ。我们的假设是并发TMZ具有协同/放射增敏机制,使RT时序的重要性降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号